These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12463072)

  • 1. Beyond cholesterol. Inflammation is emerging as a major risk factor--and not just in heart disease.
    Park A
    Time; 2002 Nov; 160(22):74-5. PubMed ID: 12463072
    [No Abstract]   [Full Text] [Related]  

  • 2. Markers of inflammation and cardiovascular disease: clinical applications of C-reactive protein determination.
    Martínez VB; González-Juanatey JR
    Am J Cardiovasc Drugs; 2009; 9 Suppl 1():3-7. PubMed ID: 20000881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-reactive protein testing comes of age. Measuring low-grade inflammation can help refine cardiovascular risk.
    Harv Heart Lett; 2009 Feb; 19(6):2. PubMed ID: 19575518
    [No Abstract]   [Full Text] [Related]  

  • 4. [The clinical application of C-reactive protein in prognosis and prevention of cardiovascular disease].
    Feng RF
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1370-3. PubMed ID: 14584491
    [No Abstract]   [Full Text] [Related]  

  • 5. Does C-reactive protein predict cardiovascular events in women better than LDL?
    Stevermer JJ
    J Fam Pract; 2003 Mar; 52(3):185-6. PubMed ID: 12620166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The revival of an old diagnostic marker: C-reactive protein].
    Sela B
    Harefuah; 2001 Jun; 140(6):541-6. PubMed ID: 11420859
    [No Abstract]   [Full Text] [Related]  

  • 7. [C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women].
    Biasucci LM
    Ital Heart J Suppl; 2000 Aug; 1(8):1066-7. PubMed ID: 10993018
    [No Abstract]   [Full Text] [Related]  

  • 8. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group.
    Smith SC; Anderson JL; Cannon RO; Fadl YY; Koenig W; Libby P; Lipshultz SE; Mensah GA; Ridker PM; Rosenson R; ;
    Circulation; 2004 Dec; 110(25):e550-3. PubMed ID: 15611380
    [No Abstract]   [Full Text] [Related]  

  • 9. [JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].
    Olsson AG
    Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1471-5. PubMed ID: 19579435
    [No Abstract]   [Full Text] [Related]  

  • 10. Inflammatory findings.
    Comarow A
    US News World Rep; 2005 Jan; 138(2):74. PubMed ID: 15697188
    [No Abstract]   [Full Text] [Related]  

  • 11. A better way to predict cardiovascular risk. We know how important cholesterol levels are, but what about inflammation?
    Harv Womens Health Watch; 2007 Apr; 14(8):1-2. PubMed ID: 17441261
    [No Abstract]   [Full Text] [Related]  

  • 12. Beyond cholesterol: a new clue to heart disease.
    Johns Hopkins Med Lett Health After 50; 2003 Mar; 15(1):4-5. PubMed ID: 12703447
    [No Abstract]   [Full Text] [Related]  

  • 13. Should we measure CRP levels to assess cardiovascular risk?
    Hadley RD; Graber MA
    JAAPA; 2003 Jan; 16(1):17-9. PubMed ID: 12635434
    [No Abstract]   [Full Text] [Related]  

  • 14. High sensitivity C-reactive protein for predicting cardiovascular disease: an inflammatory hypothesis.
    Blake GJ; Ridker PM
    Eur Heart J; 2001 Mar; 22(5):349-52. PubMed ID: 11207073
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of cardiovascular risk factors and serum ferritin with C-reactive protein.
    Sung KC; Kang JH; Shin HS
    Arch Med Res; 2007 Jan; 38(1):121-5. PubMed ID: 17174735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A message from the heart.
    Comarow A
    US News World Rep; 2002 Nov; 133(20):54-6, 59-60, 61. PubMed ID: 12503183
    [No Abstract]   [Full Text] [Related]  

  • 18. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit.
    Ridker PM
    Am Heart J; 2004 Jul; 148(1 Suppl):S19-26. PubMed ID: 15211329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum C-reactive protein as a marker for wellness assessment.
    Kao PC; Shiesh SC; Wu TJ
    Ann Clin Lab Sci; 2006; 36(2):163-9. PubMed ID: 16682512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for targeted rather than population based screening with C-reactive protein using the National Health and Nutrition Examination Survey (1999 to 2002).
    Guttormsen BN; Stein JH; McBride PE; Cullen MW; Gangnon R; Keevil JG
    Am J Cardiol; 2007 Oct; 100(7):1130-3. PubMed ID: 17884376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.